Hosted on MSN2mon
Clinical trial: Adjuvant tamoxifen may reduce recurrence risk for patients with 'good-risk' DCIS who forgo radiationWright, MD, chair of the Department of Radiation Oncology at the University of North Carolina and the Lineberger Comprehensive Cancer Center in Chapel Hill. "I believe that being able to provide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback